| |
 |
|
|
|
Karolinska Investment Fund was established in
1999 by the Karolinska
Institute and Alecta
(former Försäkringsbolaget SPP, ömsesidigt).
 The Karolinska
Institute, founded in 1810, has a pure medical focus and is
the largest centre for medical education and research in Sweden.
The Karolinska Institute has 700 research groups, over 900 additional researchers and 2 000 PhD students. Each year 350 PhD theses in
the biomedical field are defended. Approximately 4,000 articles
are published annually, and over 45% of all the nation’s federally
funded medical research, close to 40% of all privately funded
cancer research, and 36% of all biotechnology research is carried
out by Karolinska Institute scientists within 10,000 research
projects.
Through his will (in 1895), Alfred Nobel decided that the
Karolinska Institute should be responsible for selecting the
winner of the Nobel
Prize in Physiology or
Medicine. This commission has given the Institute a wide network
of contacts in the medical research community. Five researchers
from the Karolinska Institute have been awarded the Nobel Prize. |
 |
|
|
|
Alecta develops, offers and manages
collectively agreed pension plans.
The company’s core business is the occupational pension ITP, which
is based on an agreement between The Confederation of Swedish
Enterprise (Svenskt Näringsliv) and The Federation of Salaried
Employees in Industry and Services (PTK).
Alecta is the largest manager of pension assets in the Nordic
region. In recent years, Alecta has developed extensive competence
in the area of health and rehabilitation. |
|
|
|
|
|
|
|
|
